[Novel possibilities of development and therapeutical application of liposomes].
Properties and possibilities of application of liposomal drug delivery systems are summarized in this review. Technological and biopharmeceutical criteria that have to be taken into consideration in the course of development of biocompatible liposomes are discussed. The manner and possibilities of active and passive targeting are shown according to the literary data and special liposome-based drug delivery systems responsible for pathologic or arteficial stimuli are introduced.
Bozó
Tamás
T
Pécsi Tudományegyetem Altalános Orvostudományi Kar, Gyógyszerésztudományi Szak, Gyógyszertechnológiai és Biofarmáciai Intézet, Pécs, Rókus utca 2.-7624.
Pál
Szilárd
S
Dévay
Attila
A
D000666:Amphotericin B / Q000627:therapeutic use; D016477:Artifacts; D001672:Biocompatible Materials / Q000627:therapeutic use; D003561:Cytarabine / Q000627:therapeutic use; D004317:Doxorubicin / Q000627:therapeutic use; D006801:Humans; D007118:Immunoassay / Q000379:methods; D008081:Liposomes / Q000627:therapeutic use*; D009020:Morphine / Q000627:therapeutic use
D001672:Biocompatible Materials; D008081:Liposomes; D003561:Cytarabine; D009020:Morphine; D000666:Amphotericin B; D004317:Doxorubicin